Medtronic(US:MDT) Seeking Alphaยท2025-10-09 18:56Core Viewpoint - Medtronic has successfully secured FDA approval for its Altaviva device on September 18, marking a significant milestone for the company in the pelvic health sector [1]. Group 1 - Ryan Weispfenning, Vice President and Head of Investor Relations, is leading the call to showcase the Altaviva device [1]. - The event is being recorded, and a replay will be available on the company's website shortly after the call [2]. - The call includes forward-looking statements and will have a Q&A session for analysts and investors [2]. Group 2 - Emily Elswick, President of the Pelvic Health business, is introduced as a special guest to discuss the Altaviva device [3]. - The Pelvic Health business is one of the five segments within Medtronic's neuroscience portfolio [3].